<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02540031</url>
  </required_header>
  <id_info>
    <org_study_id>2015-06-014-003</org_study_id>
    <nct_id>NCT02540031</nct_id>
  </id_info>
  <brief_title>The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy</brief_title>
  <official_title>The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy in Patients Showing Brown Effluents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyungpook National University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyungpook National University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although adequate bowel preparation is essential for successful colonoscopy, the 23% of
      patients had shown inadequate bowel preparation. Inadequate bowel preparation may results in
      incomplete examination, increased patient's discomfort, decreased polyp detection rates,
      ultimately leading to repeated colonoscopies. One prior study showed that patients reporting
      their last rectal effluents as brown color or solid stool had a 54% chance of having fair or
      poor preparation. Thus, recent consensus guideline suggested consideration of additional oral
      preparation in patients presenting brown effluents on the day of colonoscopy. However, the
      data supporting additional oral preparation is still spares. Therefore, the investigators
      aimed to examine the impact of additional oral preparation on the quality of bowel
      preparation for colonoscopy in patients showing brown effluents on the day of colonoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of bowel preparation</measure>
    <time_frame>Day 1</time_frame>
    <description>The primary outcome will be the endoscopist's assessment of the quality of preparation using a standardized bowel preparation scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adenoma detection rate</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of adenomatous polyps</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient compliance</measure>
    <time_frame>Baseline</time_frame>
    <description>Patient compliance with preparation instructions self-reported in a pre-procedure questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Baseline</time_frame>
    <description>Patient's perception of the preparation method as self-reported on a pre-procedure questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">158</enrollment>
  <condition>Bowel Preparation Quality</condition>
  <arm_group>
    <arm_group_label>Additional oral preparation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigational or experimental arm will receive standard oral preparation plus additional oral preparation (1l of polyethylene glycol (PEG)+ascorbic acid (Asc)) for colonoscopy.
* Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard oral preparation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control arm will receive currently used oral preparation (2L of polyethylene glycol+ascorbic acid) for colonoscopy.
* Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Additional oral preparation (3L of PEG+Asc, &quot;Coolprep®&quot;)</intervention_name>
    <description>The interventional or experimental arm will receive 1l of additional PEG+Asc, &quot;Coolprep®&quot; on the day of colonoscopy
* Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g</description>
    <arm_group_label>Additional oral preparation</arm_group_label>
    <other_name>Coolprep® (TaeJoon Pharmaceuticals, Seoul, Korea):3L</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard oral preparation (2L of PEG+Asc, &quot;Coolprep®&quot;)</intervention_name>
    <description>The control arm will receive currently used oral preparation (2l of PEG+Asc, &quot;Coolprep®&quot;) for colonoscopy
* Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g</description>
    <arm_group_label>Standard oral preparation</arm_group_label>
    <other_name>Coolprep® (TaeJoon Pharmaceuticals, Seoul, Korea) : 2L</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who reporting their last rectal effluents as brown color or solid stool on
             the day colonoscopy

        Exclusion Criteria:

          -  known hypersensitivity to polyethylene glycol

          -  severe congestive heart failure [New York Heart Association (NYHA) grade III or grade
             IV]

          -  severe renal insufficiency (creatinine clearance &lt;30 ml/min)

          -  hemodynamic instability

          -  suspected intestinal obstruction or perforation

          -  compromised swallowing reflex or altered mental status

          -  pregnancy or lactating woman

          -  patients who declined to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eun Soo Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keimyung University Dongsan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yoo Jin Lee</last_name>
    <email>doctorlyj@naver.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eun Soo Kim</last_name>
    <email>dandy813@hanmail.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <zip>700-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Soo Kim, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Eun Soo Kim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Fatima H, Johnson CS, Rex DK. Patients' description of rectal effluent and quality of bowel preparation at colonoscopy. Gastrointest Endosc. 2010 Jun;71(7):1244-1252.e2. doi: 10.1016/j.gie.2009.11.053. Epub 2010 Apr 1.</citation>
    <PMID>20362286</PMID>
  </results_reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2015</study_first_submitted>
  <study_first_submitted_qc>August 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2015</study_first_posted>
  <last_update_submitted>July 25, 2016</last_update_submitted>
  <last_update_submitted_qc>July 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyungpook National University</investigator_affiliation>
    <investigator_full_name>Eun Soo Kim, MD, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Polyethylene glycol 3350</mesh_term>
    <mesh_term>Sodium sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

